# Rubén Niesvizky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ruben-niesvizky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,750 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 66 |
| i10-index | 193 |
| Last Known Institution | NewYork–Presbyterian Hospital |
| OpenAlex ID | https://openalex.org/A5077846750 |
| Works | 498 |

## Researcher papers

- [Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results](https://scholariq.org/papers/elranatamab-in-relapsed-or-refractory-multiple-myeloma-phase-2-magnetismm-3/)
- [International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation](https://scholariq.org/papers/international-myeloma-working-group-guidelines-for-the-management-of-multiple/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [NewYork–Presbyterian Hospital](https://scholariq.org/institutions/newyork-presbyterian-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.